Log in to save to my catalogue

ANCA-associated vasculitis — clinical utility of using ANCA specificity to classify patients

ANCA-associated vasculitis — clinical utility of using ANCA specificity to classify patients

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_01352043v1

ANCA-associated vasculitis — clinical utility of using ANCA specificity to classify patients

About this item

Full title

ANCA-associated vasculitis — clinical utility of using ANCA specificity to classify patients

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Rheumatology, 2016-10, Vol.12 (10), p.570-579

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Key Points
Anti-neutrophil cytoplasmic antibodies (ANCAs) specific for leukocyte proteinase 3 and myeloperoxidase — PR3-ANCAs and MPO-ANCAs, respectively — define distinct conditions among patients with ANCA-associated vasculitides (AAV)
Classification of patients with small-vessel vasculitis based on ANCA specificity is feasible and could pr...

Alternative Titles

Full title

ANCA-associated vasculitis — clinical utility of using ANCA specificity to classify patients

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_hal_01352043v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_01352043v1

Other Identifiers

ISSN

1759-4790,1759-4804

E-ISSN

1759-4804

DOI

10.1038/nrrheum.2016.123

How to access this item